CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹4,155 Cr | ₹2,835 Cr | ₹2,559 Cr | ₹2,401 Cr | ₹1,547 Cr |
What is the latest Profit After Tax of CIPLA ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹4,155 Cr |
| Mar2024 | ₹2,835 Cr |
| Mar2023 | ₹2,559 Cr |
| Mar2022 | ₹2,401 Cr |
| Mar2021 | ₹1,547 Cr |
How is Profit After Tax of CIPLA Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,155 Cr | 46.55 | |
| Mar2024 | ₹2,835 Cr | 10.78 | |
| Mar2023 | ₹2,559 Cr | 6.59 | |
| Mar2022 | ₹2,401 Cr | 55.23 | |
| Mar2021 | ₹1,547 Cr | - | |
Compare Profit After Tax of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹123,726.7 Cr | 1.2% | -1.4% | -4.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,419.0 Cr | 3.5% | 6.2% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,857.0 Cr | -2.7% | -0.7% | 11% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,953.0 Cr | 0.6% | 9.1% | 19.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,906.0 Cr | 3.9% | 0.6% | -3.7% | Stock Analytics | |
| MANKIND PHARMA | ₹93,568.2 Cr | 1.4% | -6.9% | -15.2% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.2% |
-1.4% |
-4.1% |
| SENSEX | 1.6% |
2.7% |
6.3% |
You may also like the below Video Courses